A carregar...
Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis
Background: Multiple myeloma (MM) is incurable in spite of recent treatment improvements, highlighting the development of new therapies. Chimeric antigen receptor (CAR) T-cell therapy has dramatically changed the therapeutic effectiveness in high-risk B-cell malignancies. For relapsed/refractory mul...
Na minha lista:
| Publicado no: | Int J Med Sci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7976586/ https://ncbi.nlm.nih.gov/pubmed/33746596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.46811 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|